{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:48:35Z","timestamp":1772034515485,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007509","name":"Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica","doi-asserted-by":"publisher","award":["2015"],"award-info":[{"award-number":["2015"]}],"id":[{"id":"10.13039\/501100007509","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011596","name":"Conselleria d'Educaci\u00f3, Investigaci\u00f3, Cultura i Esport","doi-asserted-by":"crossref","award":["SAF2013-49063-C2-1-R"],"award-info":[{"award-number":["SAF2013-49063-C2-1-R"]}],"id":[{"id":"10.13039\/501100011596","id-type":"DOI","asserted-by":"crossref"}]},{"name":"MINECO Plan Estatal I+D Retos","award":["SAF2016-80363-C2-1-R"],"award-info":[{"award-number":["SAF2016-80363-C2-1-R"]}]},{"name":"MINECO Plan Estatal I+D Retos","award":["SAF2014-54371"],"award-info":[{"award-number":["SAF2014-54371"]}]},{"name":"FUCAP"},{"name":"Menarini"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:sec>\n                <jats:title>Abstract<\/jats:title>\n                <jats:p>Chronic obstructive pulmonary disease (COPD) is a chronic and often progressive disorder with a heterogeneous presentation and frequent systemic manifestations. Several aspects like persistence in smoking habit, continuous exacerbations, alpha-1-antitrypsin deficiency and inflammatory-immune response, are involved in the pathophysiology and progression of the disease. However, the role of natural killer (NK) cells remains controversial. Otherwise, human cytomegalovirus (HCMV) infection has been reported to induce an adaptive differentiation and expansion of an NK cell subset which carries the CD94\/NKG2C receptor, which may contribute to an upset immune defense. For these reasons, our objective is to assess the distribution of NK cells and their subset in COPD patients and some of its phenotypes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Peripheral blood samples were obtained from 66 COPD patients. HCMV serology and the proportions of total NK cells and the NKG2C+ and NKG2A+ subsets were evaluated by flow cytometry. The <jats:italic>NKG2C<\/jats:italic> genotype was also assessed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Eighty-eight per cent of COPD patients were HCMV(+), and the proportions of total NK cells were higher in patients with severe-very severe airway obstruction than in those with only mild-moderate involvement. There were no differences in the proportions of NKG2C+ cells between controls and COPD, either among COPD patients classified by severity of the disease. However, the percentage of NKG2C+ cells were higher in COPD patients with frequent exacerbations than in occasional exacerbators, and higher in cases with reduced lean mass (Fat free mass index) than in those with normal nutritional status.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These results suggest a relationship between levels of NKG2C+ cells in COPD patients and clinical variables closely linked to a poor\/worse prognosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-020-1323-4","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T15:02:39Z","timestamp":1583334159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Adaptive NKG2C+ natural killer cells are related to exacerbations and nutritional abnormalities in COPD patients"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6567-0916","authenticated-orcid":false,"given":"Sergi","family":"Pascual-Guardia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Ataya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Ram\u00edrez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Y\u00e9lamos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Chalela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salom\u00e9","family":"Bellido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"L\u00f3pez-Botet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquim","family":"Gea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,4]]},"reference":[{"issue":"7","key":"1323_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.arbres.2017.06.001","volume":"53","author":"CF Vogelmeier","year":"2017","unstructured":"Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Erratum to \"global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary\" [arch Bronconeumol. 2017;53:128-49]. Arch Bronconeumol. 2017;53(7):411\u20132.","journal-title":"Arch Bronconeumol"},{"issue":"6","key":"1323_CR2","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.arbres.2017.03.018","volume":"53","author":"M Miravitlles","year":"2017","unstructured":"Miravitlles M, Soler-Cataluna JJ, Calle M, Molina J, Almagro P, Quintano JA, et al. Spanish guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological treatment of stable phase. Arch Bronconeumol. 2017;53(6):324\u201335.","journal-title":"Arch Bronconeumol"},{"issue":"5","key":"1323_CR3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1136\/thx.2010.154484","volume":"66","author":"J Garcia-Aymerich","year":"2011","unstructured":"Garcia-Aymerich J, Gomez FP, Benet M, Farrero E, Basagana X, Gayete A, et al. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax. 2011;66(5):430\u20137.","journal-title":"Thorax."},{"issue":"6","key":"1323_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.arbres.2017.04.005","volume":"53","author":"JP de-Torres","year":"2017","unstructured":"de-Torres JP, Marin JM. Differences between GesEPOC and GOLD in 2017. Arch Bronconeumol. 2017;53(6):295\u20136.","journal-title":"Arch Bronconeumol"},{"issue":"Suppl 12","key":"1323_CR5","doi-asserted-by":"publisher","first-page":"S1332","DOI":"10.21037\/jtd.2018.02.66","volume":"10","author":"J Gea","year":"2018","unstructured":"Gea J, Sancho-Munoz A, Chalela R. Nutritional status and muscle dysfunction in chronic respiratory diseases: stable phase versus acute exacerbations. J Thorac Dis. 2018;10(Suppl 12):S1332\u2013S54.","journal-title":"J Thorac Dis"},{"issue":"3","key":"1323_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nri2254","volume":"8","author":"PJ Barnes","year":"2008","unstructured":"Barnes PJ. Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol. 2008;8(3):183\u201392.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"1323_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1042\/CS20070356","volume":"114","author":"L Fairclough","year":"2008","unstructured":"Fairclough L, Urbanowicz RA, Corne J, Lamb JR. Killer cells in chronic obstructive pulmonary disease. Clin Sci (Lond). 2008;114(8):533\u201341.","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"1323_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1440-1843.2012.02287.x","volume":"18","author":"G Hodge","year":"2013","unstructured":"Hodge G, Mukaro V, Holmes M, Reynolds PN, Hodge S. Enhanced cytotoxic function of natural killer and natural killer T-like cells associated with decreased CD94 (Kp43) in the chronic obstructive pulmonary disease airway. Respirology. 2013;18(2):369\u201376.","journal-title":"Respirology."},{"key":"1323_CR9","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.3389\/fimmu.2019.01416","volume":"10","author":"J Cong","year":"2019","unstructured":"Cong J, Wei H. Natural killer cells in the lungs. Front Immunol. 2019;10:1416.","journal-title":"Front Immunol"},{"issue":"4","key":"1323_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/15412550600976868","volume":"3","author":"S Hodge","year":"2006","unstructured":"Hodge S, Hodge G, Nairn J, Holmes M, Reynolds PN. Increased airway granzyme b and perforin in current and ex-smoking COPD subjects. COPD. 2006;3(4):179\u201387.","journal-title":"COPD."},{"issue":"1","key":"1323_CR11","doi-asserted-by":"publisher","first-page":"9562","DOI":"10.1038\/s41598-017-10126-2","volume":"7","author":"M Suzuki","year":"2017","unstructured":"Suzuki M, Sze MA, Campbell JD, Brothers JF 2nd, Lenburg ME, McDonough JE, et al. The cellular and molecular determinants of emphysematous destruction in COPD. Sci Rep. 2017;7(1):9562.","journal-title":"Sci Rep"},{"issue":"3","key":"1323_CR12","first-page":"253","volume":"33","author":"S Astegiano","year":"2010","unstructured":"Astegiano S, Sidoti F, Costa C, Ostorero A, Alotto D, Castagnoli C, et al. Human cytomegalovirus load in fresh and glycerolized skin grafts. New Microbiol. 2010;33(3):253\u20136.","journal-title":"New Microbiol"},{"issue":"1","key":"1323_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1128\/CMR.00034-08","volume":"22","author":"T Crough","year":"2009","unstructured":"Crough T, Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev. 2009;22(1):76\u201398 Table of Contents.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"1323_CR14","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/cmi.2015.4","volume":"13","author":"DB Tan","year":"2016","unstructured":"Tan DB, Amran FS, Teo TH, Price P, Moodley YP. Levels of CMV-reactive antibodies correlate with the induction of CD28(null) T cells and systemic inflammation in chronic obstructive pulmonary disease (COPD). Cell Mol Immunol. 2016;13(4):551\u20133.","journal-title":"Cell Mol Immunol"},{"issue":"12","key":"1323_CR15","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1093\/infdis\/jiu837","volume":"211","author":"E Poole","year":"2015","unstructured":"Poole E, Juss JK, Krishna B, Herre J, Chilvers ER, Sinclair J. Alveolar macrophages isolated directly from human Cytomegalovirus (HCMV)-seropositive individuals are sites of HCMV reactivation in vivo. J Infect Dis. 2015;211(12):1936\u201342.","journal-title":"J Infect Dis"},{"issue":"2","key":"1323_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.smim.2014.03.002","volume":"26","author":"M Lopez-Botet","year":"2014","unstructured":"Lopez-Botet M, Muntasell A, Vilches C. The CD94\/NKG2C+ NK-cell subset on the edge of innate and adaptive immunity to human cytomegalovirus infection. Semin Immunol. 2014;26(2):145\u201351.","journal-title":"Semin Immunol"},{"key":"1323_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev.immunol.17.1.189","volume":"17","author":"CA Biron","year":"1999","unstructured":"Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol. 1999;17:189\u2013220.","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"1323_CR18","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1182\/blood-2004-05-2058","volume":"104","author":"M Guma","year":"2004","unstructured":"Guma M, Angulo A, Vilches C, Gomez-Lozano N, Malats N, Lopez-Botet M. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood. 2004;104(12):3664\u201371.","journal-title":"Blood."},{"issue":"1","key":"1323_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4049\/jimmunol.1601236","volume":"198","author":"D Redondo-Pachon","year":"2017","unstructured":"Redondo-Pachon D, Crespo M, Yelamos J, Muntasell A, Perez-Saez MJ, Perez-Fernandez S, et al. Adaptive NKG2C+ NK cell response and the risk of Cytomegalovirus infection in kidney transplant recipients. J Immunol. 2017;198(1):94\u2013101.","journal-title":"J Immunol"},{"issue":"12","key":"1323_CR20","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1002\/eji.201343773","volume":"43","author":"A Muntasell","year":"2013","unstructured":"Muntasell A, Lopez-Montanes M, Vera A, Heredia G, Romo N, Penafiel J, et al. NKG2C zygosity influences CD94\/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus. Eur J Immunol. 2013;43(12):3268\u201378.","journal-title":"Eur J Immunol"},{"issue":"5","key":"1323_CR21","first-page":"406","volume":"14","author":"BJ Noble","year":"1982","unstructured":"Noble BJ. Clinical applications of perceived exertion. Med Sci Sports Exerc. 1982;14(5):406\u201311.","journal-title":"Med Sci Sports Exerc"},{"issue":"6","key":"1323_CR22","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1164\/arrd.1987.135.6.1229","volume":"135","author":"DA Mahler","year":"1987","unstructured":"Mahler DA, Rosiello RA, Harver A, Lentine T, McGovern JF, Daubenspeck JA. Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airway disease. Am Rev Respir Dis. 1987;135(6):1229\u201333.","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"1323_CR23","first-page":"217","volume":"22","author":"J Roca","year":"1986","unstructured":"Roca J, Sanchis J, Agusti-Vidal A, Segarra F, Navajas D, Rodriguez-Roisin R, et al. Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir. 1986;22(3):217\u201324.","journal-title":"Bull Eur Physiopathol Respir"},{"issue":"4 Pt 1","key":"1323_CR24","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1164\/ajrccm\/141.4_Pt_1.1026","volume":"141","author":"J Roca","year":"1990","unstructured":"Roca J, Rodriguez-Roisin R, Cobo E, Burgos F, Perez J, Clausen JL. Single-breath carbon monoxide diffusing capacity prediction equations from a Mediterranean population. Am Rev Respir Dis. 1990;141(4 Pt 1):1026\u201332.","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"1323_CR25","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/S0954-6111(98)90291-8","volume":"92","author":"J Roca","year":"1998","unstructured":"Roca J, Burgos F, Barbera JA, Sunyer J, Rodriguez-Roisin R, Castellsague J, et al. Prediction equations for plethysmographic lung volumes. Respir Med. 1998;92(3):454\u201360.","journal-title":"Respir Med"},{"issue":"6 Pt 1","key":"1323_CR26","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1164\/ajrccm.157.6.9705017","volume":"157","author":"AM Schols","year":"1998","unstructured":"Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(6 Pt 1):1791\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"1323_CR27","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/ajt.13010","volume":"15","author":"M Crespo","year":"2015","unstructured":"Crespo M, Yelamos J, Redondo D, Muntasell A, Perez-Saez MJ, Lopez-Montanes M, et al. Circulating NK-cell subsets in renal allograft recipients with anti-HLA donor-specific antibodies. Am J Transplant. 2015;15(3):806\u201314.","journal-title":"Am J Transplant"},{"issue":"2","key":"1323_CR28","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1399-0039.2012.01911.x","volume":"80","author":"M Moraru","year":"2012","unstructured":"Moraru M, Canizares M, Muntasell A, de Pablo R, Lopez-Botet M, Vilches C. Assessment of copy-number variation in the NKG2C receptor gene in a single-tube and characterization of a reference cell panel, using standard polymerase chain reaction. Tissue Antigens. 2012;80(2):184\u20137.","journal-title":"Tissue Antigens"},{"issue":"2","key":"1323_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.humimm.2016.11.006","volume":"78","author":"MT Phan","year":"2017","unstructured":"Phan MT, Chun S, Kim SH, Ali AK, Lee SH, Kim S, et al. Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicity. Hum Immunol. 2017;78(2):103\u201312.","journal-title":"Hum Immunol"},{"issue":"8","key":"1323_CR30","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1099\/vir.0.000167","volume":"96","author":"C Robles","year":"2015","unstructured":"Robles C, Casabonne D, Benavente Y, Costas L, Gonzalez-Barca E, Aymerich M, et al. Seroreactivity against Merkel cell polyomavirus and other polyomaviruses in chronic lymphocytic leukaemia, the MCC-Spain study. J Gen Virol. 2015;96(8):2286\u201392.","journal-title":"J Gen Virol"},{"issue":"5","key":"1323_CR31","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","volume":"9","author":"E Vivier","year":"2008","unstructured":"Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol. 2008;9(5):503\u201310.","journal-title":"Nat Immunol"},{"issue":"2","key":"1323_CR32","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/JLB.2AB0418-158RR","volume":"106","author":"Kayla A. Holder","year":"2019","unstructured":"Holder KA, Grant MD. Human cytomegalovirus IL-10 augments NK cell cytotoxicity. J Leukoc Biol. 2019;106(2):447\u2013454.","journal-title":"Journal of Leukocyte Biology"},{"key":"1323_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mad.2016.06.010","volume":"158","author":"M Lopez-Botet","year":"2016","unstructured":"Lopez-Botet M, Muntasell A, Martinez-Rodriguez JE, Lopez-Montanes M, Costa-Garcia M, Pupuleku A. Development of the adaptive NK cell response to human cytomegalovirus in the context of aging. Mech Ageing Dev. 2016;158:23\u20136.","journal-title":"Mech Ageing Dev"},{"issue":"Suppl 1","key":"1323_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000196097","volume":"59","author":"U Costabel","year":"1992","unstructured":"Costabel U, Maier K, Teschler H, Wang YM. Local immune components in chronic obstructive pulmonary disease. Respir. 1992;59(Suppl 1):17\u20139.","journal-title":"Respir."},{"key":"1323_CR35","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1465-9921-11-76","volume":"11","author":"RA Urbanowicz","year":"2010","unstructured":"Urbanowicz RA, Lamb JR, Todd I, Corne JM, Fairclough LC. Enhanced effector function of cytotoxic cells in the induced sputum of COPD patients. Respir Res. 2010;11:76.","journal-title":"Respir Res"},{"key":"1323_CR36","first-page":"721782","volume":"2013","author":"Y Tang","year":"2013","unstructured":"Tang Y, Li X, Wang M, Zou Q, Zhao S, Sun B, et al. Increased numbers of NK cells, NKT-like cells, and NK inhibitory receptors in peripheral blood of patients with chronic obstructive pulmonary disease. Clin Dev Immunol. 2013;2013:721782.","journal-title":"Clin Dev Immunol"},{"issue":"5","key":"1323_CR37","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.pupt.2012.06.009","volume":"25","author":"C Folli","year":"2012","unstructured":"Folli C, Chiappori A, Pellegrini M, Garelli V, Riccio AM, De Ferrari L, et al. COPD treatment: real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-gamma secretion. Pulm Pharmacol Ther. 2012;25(5):371\u20136.","journal-title":"Pulm Pharmacol Ther"},{"issue":"7","key":"1323_CR38","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1164\/ajrccm.163.7.2002015","volume":"163","author":"A Prieto","year":"2001","unstructured":"Prieto A, Reyes E, Bernstein ED, Martinez B, Monserrat J, Izquierdo JL, et al. Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophosphopeptical (inmunoferon). Am J Respir Crit Care Med. 2001;163(7):1578\u201383.","journal-title":"Am J Respir Crit Care Med"},{"key":"1323_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1465-9921-10-53","volume":"10","author":"RA Urbanowicz","year":"2009","unstructured":"Urbanowicz RA, Lamb JR, Todd I, Corne JM, Fairclough LC. Altered effector function of peripheral cytotoxic cells in COPD. Respir Res. 2009;10:53.","journal-title":"Respir Res"},{"issue":"3","key":"1323_CR40","doi-asserted-by":"publisher","first-page":"e58556","DOI":"10.1371\/journal.pone.0058556","volume":"8","author":"J Wang","year":"2013","unstructured":"Wang J, Urbanowicz RA, Tighe PJ, Todd I, Corne JM, Fairclough LC. Differential activation of killer cells in the circulation and the lung: a study of current smoking status and chronic obstructive pulmonary disease (COPD). PLoS One. 2013;8(3):e58556.","journal-title":"PLoS One"},{"key":"1323_CR41","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1465-9921-8-62","volume":"8","author":"MC Morissette","year":"2007","unstructured":"Morissette MC, Parent J, Milot J. Perforin, granzyme B, and FasL expression by peripheral blood T lymphocytes in emphysema. Respir Res. 2007;8:62.","journal-title":"Respir Res"},{"issue":"9","key":"1323_CR42","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1164\/rccm.201712-2513OC","volume":"198","author":"DK Finch","year":"2018","unstructured":"Finch DK, Stolberg VR, Ferguson J, Alikaj H, Kady MR, Richmond BW, et al. Lung dendritic cells drive natural killer cytotoxicity in chronic obstructive pulmonary disease via IL-15Ralpha. Am J Respir Crit Care Med. 2018;198(9):1140\u201350.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"1323_CR43","doi-asserted-by":"publisher","first-page":"e103840","DOI":"10.1371\/journal.pone.0103840","volume":"9","author":"CM Freeman","year":"2014","unstructured":"Freeman CM, Stolberg VR, Crudgington S, Martinez FJ, Han MK, Chensue SW, et al. Human CD56+ cytotoxic lung lymphocytes kill autologous lung cells in chronic obstructive pulmonary disease. PLoS One. 2014;9(7):e103840.","journal-title":"PLoS One"},{"issue":"3","key":"1323_CR44","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1164\/rccm.200501-124OC","volume":"173","author":"RJ Boyton","year":"2006","unstructured":"Boyton RJ, Smith J, Ward R, Jones M, Ozerovitch L, Wilson R, et al. HLA-C and killer cell immunoglobulin-like receptor genes in idiopathic bronchiectasis. Am J Respir Crit Care Med. 2006;173(3):327\u201333.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1323_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2007.03424.x","volume":"149","author":"RJ Boyton","year":"2007","unstructured":"Boyton RJ, Altmann DM. Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clin Exp Immunol. 2007;149(1):1\u20138.","journal-title":"Clin Exp Immunol"},{"issue":"Suppl 1","key":"1323_CR46","doi-asserted-by":"publisher","first-page":"S175","DOI":"10.1080\/13693780802163370","volume":"47","author":"RJ Boyton","year":"2009","unstructured":"Boyton RJ. Regulation of immunity in bronchiectasis. Med Mycol. 2009;47(Suppl 1):S175\u201382.","journal-title":"Med Mycol"},{"issue":"8","key":"1323_CR47","doi-asserted-by":"publisher","first-page":"4460","DOI":"10.4049\/jimmunol.0903654","volume":"184","author":"GT Motz","year":"2010","unstructured":"Motz GT, Eppert BL, Wortham BW, Amos-Kroohs RM, Flury JL, Wesselkamper SC, et al. Chronic cigarette smoke exposure primes NK cell activation in a mouse model of chronic obstructive pulmonary disease. J Immunol. 2010;184(8):4460\u20139.","journal-title":"J Immunol"},{"key":"1323_CR48","first-page":"1","volume":"8","author":"JD Morrow","year":"2015","unstructured":"Morrow JD, Qiu W, Chhabra D, Rennard SI, Belloni P, Belousov A, et al. Identifying a gene expression signature of frequent COPD exacerbations in peripheral blood using network methods. BMC Med Genet. 2015;8:1.","journal-title":"BMC Med Genet"},{"issue":"Suppl 1","key":"1323_CR49","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/S0954-6111(11)70006-3","volume":"105","author":"M Rijavec","year":"2011","unstructured":"Rijavec M, Volarevic S, Osolnik K, Kosnik M, Korosec P. Natural killer T cells in pulmonary disorders. Respir Med. 2011;105(Suppl 1):S20\u20135.","journal-title":"Respir Med"},{"key":"1323_CR50","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1471-2466-14-85","volume":"14","author":"G Hodge","year":"2014","unstructured":"Hodge G, Holmes M, Jersmann H, Reynolds PN, Hodge S. Targeting peripheral blood pro-inflammatory cytotoxic lymphocytes by inhibiting CD137 expression: novel potential treatment for COPD. BMC Pulm Med. 2014;14:85.","journal-title":"BMC Pulm Med"},{"key":"1323_CR51","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1465-9921-11-128","volume":"11","author":"E Roos-Engstrand","year":"2010","unstructured":"Roos-Engstrand E, Pourazar J, Behndig AF, Blomberg A, Bucht A. Cytotoxic T cells expressing the co-stimulatory receptor NKG2 D are increased in cigarette smoking and COPD. Respir Res. 2010;11:128.","journal-title":"Respir Res"},{"issue":"3","key":"1323_CR52","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1172\/JCI34462","volume":"119","author":"MT Borchers","year":"2009","unstructured":"Borchers MT, Wesselkamper SC, Curull V, Ramirez-Sarmiento A, Sanchez-Font A, Garcia-Aymerich J, et al. Sustained CTL activation by murine pulmonary epithelial cells promotes the development of COPD-like disease. J Clin Invest. 2009;119(3):636\u201349.","journal-title":"J Clin Invest"},{"issue":"9","key":"1323_CR53","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.4049\/jimmunol.1102643","volume":"188","author":"BW Wortham","year":"2012","unstructured":"Wortham BW, Eppert BL, Motz GT, Flury JL, Orozco-Levi M, Hoebe K, et al. NKG2D mediates NK cell hyperresponsiveness and influenza-induced pathologies in a mouse model of chronic obstructive pulmonary disease. J Immunol. 2012;188(9):4468\u201375.","journal-title":"J Immunol"},{"issue":"16","key":"1323_CR54","doi-asserted-by":"publisher","first-page":"7543","DOI":"10.1128\/JVI.75.16.7543-7554.2001","volume":"75","author":"C Soderberg-Naucler","year":"2001","unstructured":"Soderberg-Naucler C, Streblow DN, Fish KN, Allan-Yorke J, Smith PP, Nelson JA. Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent. J Virol. 2001;75(16):7543\u201354.","journal-title":"J Virol"},{"issue":"12","key":"1323_CR55","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1172\/JCI119871","volume":"100","author":"C Soderberg-Naucler","year":"1997","unstructured":"Soderberg-Naucler C, Fish KN, Nelson JA. Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J Clin Invest. 1997;100(12):3154\u201363.","journal-title":"J Clin Invest"},{"key":"1323_CR56","doi-asserted-by":"crossref","unstructured":"Forte E, Swaminathan S, Schroeder MW, Kim JY, Terhune SS, Hummel M. Tumor Necrosis Factor Alpha Induces Reactivation of Human Cytomegalovirus Independently of Myeloid Cell Differentiation following Posttranscriptional Establishment of Latency. MBio. 2018;9(5).","DOI":"10.1128\/mBio.01560-18"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-020-1323-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-020-1323-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-020-1323-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:34:57Z","timestamp":1614818097000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-020-1323-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,4]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1323"],"URL":"https:\/\/doi.org\/10.1186\/s12931-020-1323-4","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,4]]},"assertion":[{"value":"18 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study designed complied with the Declaration of Helsinki for human beings and was approved by Clinical Research and Ethics Committee of Hospital del Mar. All participants provided signed informed consent after receiving complete and detailed information on the study and its objectives.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}